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ABSTRACT 
The glomerular filtration barrier (GFB) plays a critical role in ensuing protein free urine. 
The integrity of the GFB is compromised during hypoxia that prevails during extreme 
physiological conditions. However, the mechanism by which glomerular permselectivity 
is compromised during hypoxia remains enigmatic. Rats exposed to hypoxia showed a 
decreased glomerular filtration rate, podocyte foot-processes effacement, and 
proteinuria. Accumulation of HIF1α in podocytes resulted in elevated expression of 
ZEB2 and decreased expression of E- and P-cadherin. We also demonstrated that 
HIF1α binds to HRE localized in the ZEB2 promoter. Furthermore, HIF1α also induced 
the expression of ZEB2-natural antisense transcript, which is known to increase the 
efficiency of ZEB2 translation. Ectopic expression of ZEB2 induced loss of E- and P-
cadherin and is associated with enhanced motility of podocytes during hypoxic 
conditions. ZEB2 knockdown abrogated hypoxia-induced decrease in podocyte 
permselectivity. This study suggests that hypoxia leads to activation of HIF1α/ZEB2 
axis, resulting in podocyte injury and poor renal outcome. 
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INTRODUCTION 
 
Oxygen is a vital element and supports most of the metabolic events in higher 
organisms. The continuous supply of adequate levels of oxygen is crucial for normal 
functioning of the human body. However, human physiology is challenged with extreme 
environmental conditions resulting in hypoxia, a state of deficiency of oxygen in the 
blood and tissues. Hypoxia affects the homeostasis and functioning of various organs 
including kidneys. Kidneys possess low-resistance microvasculature that is exposed to 
both high volume and continuous perfusion. The kidneys have a high oxygen demand, 
so as to facilitate energy dependent basic renal functions such as active salt absorption 
(1). The constraints of low oxygen supply, dictated by both renal architecture and high 
oxygen demand, coalesce to make the kidney vulnerable to physiologic, environmental 
and pathological stresses that cause hypoxia. The limitation in renal tissue oxygen 
supply during chronic hypoxia exposes the kidneys to hypoxia-induced adaptations and 
has long been recognized as an important factor in the pathogenesis of acute renal 
injury (2-6). 
The vertebrate kidneys play an essential role in the maintenance of homeostasis 
via its role in the filtration of plasma and the regulation of water, electrolyte, and acid-
base balance. The function of the kidneys is to ensure almost protein free ultra-filtrated 
urine. The presence of proteins in the urine (proteinuria) is an indicator of renal injury, 
particularly aberrations in the glomerular filtration barrier (GFB). The crucial components 
of GFB include the glomerular capillary endothelium, basement membrane and 
glomerular podocytes (7). Albuminuria is an index of adverse renal outcome that can be 
assessed by measuring albumin levels in urine. Microalbuminuria describes levels of 
urine albumin ranging from 30 to 300 mg/24 hours, and macroalbuminuria describes a 
urinary albumin excretion of ≥300 mg/24 hours. The condition of macroalbuminuria 
often progresses to overt proteinuria and even to end-stage renal disease (ESRD) and 
is driven by an array of interlinked risk factors such as anemia, atherosclerosis, 
hyperglycemia, hypertension, repeated episodes of acute kidney injury, smoking, stroke 
and sleep apnea etc. It has been well established that all these factors subject the 
kidneys to hypoxia (8-10). It was proposed that chronic hypoxia is the common pathway 
that leads to the ESRD (11) and progression of chronic renal disease (2,5,10-13). 
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Population-based studies demonstrated that approximately 10 - 20% of adults 
have proteinuria in their lifetime (14,15). The incidence of ESRD has already reached 
epidemic proportions in many countries. Furthermore, the rates of ESRD among the 
elderly are disproportionally high. Considering the magnitude of the population with 
proteinuria and association of proteinuria with the clinical conditions wherein hypoxia 
prevails, it is important to understand the underlying mechanism of renal dysfunction to 
develop preventive and therapeutic strategies. Our understanding of the physiological 
and cellular events that transduce hypoxia-mediated events to adverse glomerular 
function is very limiting. In the present study, we investigated the mechanism of renal 
dysfunction following chronic hypoxia in rats and found that hypoxia results in elevated 
expression of hypoxia-inducible factor-1 (HIF1α) in the glomerular region. Elevated 
HIF1α in turn induced zinc finger E-box binding homeobox 2 (ZEB2) expression, both by 
directly interacting with the ZEB2 promoter and by increasing expression of a ZEB2-
Natural Antisense Transcript (ZEB2-NAT). Ectopic expression of ZEB2 induced loss of 
E- and P-cadherin and was associated with enhanced migration of cells. Finally, 
hypoxia ablated the podocyte permselectivity, whereas loss of ZEB2 knockdown 
abrogated this effect. Elevated expression of ZEB2 is implicated in podocyte epithelial-
mesenchymal transition (EMT) and foot-process effacement during chronic hypoxia. We 
conclude that hyperactivity of the HIF1α-ZEB2 axis is one of the mechanisms by which 
acute systemic hypoxia provokes poor renal outcome.  
 
MATERIALS AND METHODS 
 
Reagents and plasmids: 
Antibodies for P-cadherin (#sc-1501), WT1 (#sc-192), Nephrin (#sc-376522), ZO1 (#sc-
33725) were obtained from Santa Cruz Biotechnology (Dallas, TX, USA); ZEB2 (#PA5-
20980) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Actin 
(#4970), CD2AP (#2135) HIF1α (#14179, #79233) N-cadherin (#4061) MMP2 (#4022), 
E-cadherin (#3195), MMP9 (#3852), MMP2 (#4022), VEGF (#9943), TG2 (#73612), 
Vimentin (#5741), β-Catenin (#8480), Histone3 (#4499), FSP1 (#13018) were procured 
from Cell-Signaling Technologies (Danvers, MA, USA). Podocin antibody is a gift from 
Rakesh Verma (University of Michigan, Ann Arbor) Secondary antibodies were 
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purchased from The Jackson Laboratory (Bar Harbor, ME, USA). All primers used in 
this study procured from Integrated DNA Technologies (Coralville, IA, USA). RNA 
isolation kit was purchased from Qiagen (Hilden, Germany). The high capacity cDNA 
reverse transcription kit, SYBR Green Master Mix, and ECL Western blotting reagents 
were obtained from Bio-Rad Laboratories (Hercules, CA, USA). Fetal bovine serum, 
RPMI-1640 and Trizol reagent were procured from Life Technologies (Carlsbad, CA, 
USA).  Dual-Luciferase Assay System was procured from Promega (Madison, WI, 
USA). E-cadherin-luciferase reporter construct (16) was a gift from Dr. Eric Fearon 
(University of Michigan, Ann Arbor). Hypoxia response element (HRE1&2) in the ZEB2 
promoter and ZEB2 binding sites in E-cadherin promoter (E2 box1 and E2 box3) were 
mutated using the Quick-change site-directed mutagenesis kit from Stratagene (La 
Jolla, CA, USA). ZEB2 and ZEB2-NAT promoter constructs (17) were a gift from Dr. 
Antonio García de Herreros (IMIM, Universitat Pompeu Fabra, Barcelona). ZEB2 
expression construct (18) was a gift from Dr. Anders Lund (University of Copenhagen, 
Denmark). 
 
Hypoxia treatments and surgical procedures: 
 Wistar rats weighing 190±10g, provided by the National Center for Laboratory 
Animal Sciences (Hyderabad, India), were maintained at 22°±1°C and relative humidity 
of 50±5% under a 12 h light/12 h dark cycle with food and water ad libitum. Rats were 
allowed to acclimatize to the animal facility for 1 week. Rats were randomly divided into 
normoxia and hypoxia cohorts (n=10). Rats in the normoxia group were maintained in a 
chamber with a fraction of inspired oxygen (FIO) of ~0.21 for 2 weeks. Hypoxia 
exposure to rats was performed as described earlier (19). Briefly, rats were exposed to 
FIO of 0.1 for 23 h (hypoxia) and FIO of 0.21 (normoxia) for 1 h each day and were 
maintained for 2 weeks (Fig.1A). Rats from both groups were transcardially perfused 
under anesthesia with saline. Organs were harvested and frozen immediately for further 
processing or processed for histopathology. The Institutional Animal Ethics Committee 
of the University of Hyderabad approved animal care and experimental protocols. 
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Estimation of Glomerular Filtration Rate and Urine parameters: 
 Glomerular filtration rate (GFR) was estimated in rats (n=6) following two weeks 
of exposure to hypoxia using a commercially available kit (#FIT-0415, BioPAL, 
Worcester, MA, USA). Briefly, a single intraperitoneal injection of inulin (25 mg/kg) was 
given followed by saphenous bleeds at 5, 10, 30, 60 and 90 minutes. Plasma was 
collected, and inulin concentration was estimated using functional immunoassay 
technology (FIT). Plasma clearance of inulin was determined by nonlinear regression 
using a one-phase exponential decay formula and GFR was calculated from inulin 
clearance as described earlier (20). Alternatively, spot urine was collected from control 
and experimental rats and centrifuged at 2000xg for 5 min. Urinary albumin 
(#COD11573) and creatinine (#COD11502) levels were estimated using commercially 
available assay kits (Biosystems, Barcelona, Spain). 
 
Histological Examination and Transmission Electron Microscopy: 
 Renal cortical samples were fixed in 4% neutral buffered formalin, embedded in 
paraffin, sectioned (4μm), stained with the periodic acid Schiff (PAS) stain and images 
were acquired using Olympus 5000 microscope with 40 X magnification. The glomerular 
tuft area was measured as described earlier (21). The extent of glomerulosclerosis 
index was determined in PAS-stained sections with the scoring system as described 
earlier (22,23). Briefly: 0 – normal glomerulus; 1 – mesangial expansion or sclerosis 
involving up to 25% of the glomerular tuft; 2 – sclerosis of 25 to 50%; 3 – sclerosis of 50 
to 75% and/or segmental extracapillary fibrosis or proliferation; and 4 - global sclerosis 
>75%, global extra capillary fibrosis or complete collapse of the glomerular tuft. For 
transmission electron microscopic (TEM) analysis, renal cortex from control and 
experimental rats were fixed in 2.5% glutaraldehyde for 24 h. After washing with 1 X 
PBS for four times, cortical tissues were fixed in 1% osmium tetroxide for 2 h and 
ultrathin sections (60 nm) were cut and mounted on 200 mesh copper grids. These 
copper grids were stained on a Leica EM AC20 strainer with 3% aqueous uranyl acetate 
and 3% lead citrate solution. Images were acquired on a JEOL JEM-1400 TEM 
(Peabody, MA, USA) using a Gatan ultrascan CCD camera at 2K X 2K resolution and 
120 KV.  
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Isolation of kidney glomeruli: 
 The glomeruli from the kidneys of control and rats exposed to hypoxia were 
isolated by a series of stainless sieves (24). Briefly, under aseptic conditions, 
decapsulated rat kidney slices were placed on a sieve with a size of 200 μm and gently 
grounded with a sterile syringe knob and washed with Hank's solution. The filtered 
kidney lysate was then allowed to pass through decreasing pore size sieve of 150 μm 
and as a final step; the glomeruli were then collected as a suspension on a 75 μm sieve. 
After incubation for 10 min, the suspensions were centrifuged for 5 min at 1000 RPM, 
then the supernatant was discarded, the purified glomerular precipitations were used for 
immunoblotting and gene expression studies. 
 
Silver staining of urine samples:  
 Urine samples are collected from control and rats exposed to hypoxia and protein 
concentrations were estimated using the Bradford assay. Equal amounts of protein 
were subjected to SDS-PAGE, following which gel was placed in fixing solution (50 % 
methyl alcohol and 10 % glacial acetic acid) for 1 h at RT. Then, the gel was washed 
with 50% ethanol and sensitized with sodium thiosulfate for 1 min. After washing with 
distilled water, the gel was incubated with 0.2% silver nitrate solution containing 0.037 
ml formaldehyde for 30 min. The gel was briefly washed and then developed in 6% 
sodium carbonate, containing 0.037 ml formaldehyde solution until protein bands were 
sufficiently dark. The reaction was terminated by placing the gel in 1% glacial acetic 
acid solution and visualized by Bio-Rad image analyzer. 
 
Culturing of Podocytes and HEK293T cells: 
 Human podocytes were obtained from University of Bristol, Bristol, UK and were 
cultured as described earlier (25). Briefly, podocytes were propagated at 33°C 
(permissive conditions) and 5% CO2 in RPMI-1640 medium containing 10% FBS, 100 
units/ml penicillin, 100 mg/ml streptomycin, and 1% insulin-transferrin-selenium solution. 
At ~60% confluence, these cells were transferred to 37°C (non-permissive condition) 
tissue culture incubator with 5% CO2 for 6 days to silence the temperature sensitive 
tsA58T antigen to allow podocyte differentiation. Differentiation of podocytes was 
achieved by a growth arrest and the upregulation of cyclin-dependent kinase inhibitors. 
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Cells used for experimentation were from passages 10 to 16. HEK293T cells were 
cultured in DMEM supplemented with 10% FBS, 100 units/ml penicillin, 100 mg/ml 
streptomycin and incubated at 37oC and 5% CO2. Differentiated podocytes and 
HEK293T cells were exposed to hypoxia using a modular gas chamber inside CO2 
incubator where along with carbon dioxide; nitrogen gas was supplied to reduce the 
oxygen levels to 1% for 24 h. 
 
Immunoblotting: 
 Glomerular lysates from kidney cortex, human podocytes, and HEK293T cells 
were processed for immunoblotting. An equal amount of protein from control and 
experimental samples was electrophoresed through 10% SDS-PAGE. After 
electrophoresis, the proteins were transferred to nitrocellulose membrane by 
electroblotting. The nitrocellulose membrane was then blocked in 5% non-fat milk for 1 
h, and subsequently probed with the indicated primary (1:1000 dilution) and secondary 
antibodies (1:10,000 dilution). Blots were developed using the ECL Western blotting 
substrate. 
 
Quantitative Real-time PCR analysis: 
 Total RNA from glomeruli, human podocytes, and HEK293T cells was extracted 
using Trizol reagent and, isolated using RNA isolation kit (Qiagen, Hilden, Germany). 
RT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad Laboratories). 
mRNA expression levels were normalized using the expression of β-actin and data was 
analyzed using the comparative threshold cycle method. 
 
Immunofluorescence analysis: 
 Cells cultured on coverslips were fixed with 4% paraformaldehyde, permeabilized 
with 0.1% TritonX100 and blocked with 3% BSA in 1 X PBS. Cells were incubated with 
primary antibodies for HIF1α, (1:100) and ZEB2 (1:100). HIF1α and ZEB2 were 
visualized using Cy5 Horse anti-mouse IgG (1:200) and DyLight594 anti-rabbit IgG 
(1:200) respectively (Vector labs). Prolong gold antifade with DAPI is used to mount the 
slides (Thermo Fisher Scientific). Images were acquired using a confocal microscope 
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(ZEISS) at 63X magnification. Similarly, expression of HIF1α and ZEB2 in glomerular 
sections of experimental rats was analyzed using a trinocular microscope (Leica).   
 
Cell migration assay: 
 Both differentiated human podocytes and HEK293T cells were seeded in 6 well 
plates and grown under normal growth conditions to reach 95% confluence. When the 
cells are confluent, media was aspirated, and a scratch was made in a sweeping motion 
using a 10µl sterile pipette tip. Cells were washed with pre-warmed media to remove 
debris from damaged cells. Images of cells were taken following exposure to hypoxia at 
regular time points to monitor the rate of cell migration into the wound field. The area 
covered by cells is quantified using Image J software (NIH, USA) and represented as 
the % area coverage (Cell Area/ROI Area X 100). 
  
shRNA-mediated ZEB2 knockdown in podocytes: 
 ZEB2 expression in human podocytes was knockdown as described earlier (26). 
Lentiviral particles expressing unique ZEB2 shRNA sequences and scrambled shRNA 
were purchased from Sigma-Aldrich. Podocytes were cultured in a 6-well plate under 
growth permissive conditions for 16 h. The cells were then pretreated with 6µg/ ml 
polybrene and infected with indicated lentiviral particles. Next day the medium was 
replaced with fresh medium and shRNA-infected cells were selected with 1µg/ ml 
puromycin. Puromycin-resistant cells were induced to differentiate under non-
permissive conditions, and ZEB2 expression was verified in the differentiated cells using 
qRT-PCR and immunoblotting. 
 
Albumin Influx Assay: 
 Podocyte permselectivity was assessed using paracellular albumin influx assay 
as described previously (26). Corning transwell collagen-coated 3.0μm pore 
polytetrafluoroethylene (PTFE) membrane inserts (#CLS3494, Sigma) were used in this 
study. Podocytes were seeded on the transwell insert and placed in a 12 well tissue 
culture plate, during which transwell insert serves as upper chamber and cell culture 
well serve as a bottom chamber (Fig 8A). Podocytes were cultured under non-
permissive conditions for 6 days as detailed above in the methods section. These 
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differentiated cells were exposed to hypoxia for 24 h. Subsequently, the cells were 
washed twice with 1 X PBS containing CaCl2 and MgCl2 to preserve cadherin junctions. 
Two ml of RPMI -1640 medium with 40 mg/ ml BSA was placed in the bottom chamber, 
and 300 µl of RPMI - 1640 medium (without BSA) was placed in the upper chamber. 
The cells were incubated at 37°C, aliquots of medium were collected from the upper 
chamber at regular intervals and albumin concentration was measured from these 
aliquots. 
 
Transient transfection and luciferase assay: 
 HEK293T cells were transfected with a promoter-reporter construct (ZEB2/E-
cadherin) and internal control expressing the Renilla luciferase, pRL-TK (Promega). 
293T cells were transfected using Xfect polymer (Takara) as per manufacturer’s 
instructions. After 48 h of transfection, cells were washed twice with 1 X PBS and 
harvested in 100 μl of passive lysis buffer. After a brief freeze-thaw cycle, the insoluble 
debris was removed by centrifugation at 12,000xg (4oC for 5 min), and 20 μl of 
supernatant was used for luciferase assay. The activity of the co-transfected renilla 
luciferase reporter plasmid was used to normalize transfection efficiency.  
 
ChIP assay: 
 ChIP assay was performed as described previously (27). HEK293T (2.5 X106) 
cells either naïve or exposed to hypoxia were taken for ChIP assay. Cross-linked 
chromatin from HEK293T cells was sonicated using Covaris S220 Focused-
ultrasonicator. The whole cell extract was pre-cleared using 60 μl of Protein A/G PLUS-
agarose beads and incubated overnight with anti-HIF1α and control IgG antibodies. 1 
μg of anti-HIF1α antibody was used for 100 μg of total cell lysate. Protein G agarose 
beads (Millipore, Saint Charles, MO, USA) pre-blocked with salmon sperm DNA (60 μl) 
was used for each immunoprecipitation. 10% of chromatin from each sample was 
removed before immunoprecipitation and used as input for PCR amplification. Both 
immunoprecipitated and input DNA were purified with PCR-purification kit (Qiagen, 
Valencia, CA, USA). Quantitative RT-PCR was performed on this DNA to identify the 
amount of target sequence. HRE region of the VEGFA promoter was used as a positive 
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control, while the primers that do not amplify the HRE region of the ZEB2 promoter was 
used as a negative control.  
 
Statistical Analysis: 
 SPSS software was used to apply Mann-Whitney and Kruskal-Wallis 
nonparametric tests to analyze statistical differences between the distributions of two or 
multiple independent samples, respectively. P ≤ 0.05 were considered as statistically 
significant. 
 
RESULTS 
Chronic hypoxia alters glomerular function in vivo: 
 In order to assess the impact of chronic hypoxia on renal function, we estimated 
GFR in vivo (Fig 1B). Rats exposed to hypoxia displayed reduced GFR (~29%) 
compared with control rats (2.42 Vs. 3.45 ml/min/Kg body weight). To confirm the 
adverse effect of hypoxia on renal function, we also assessed urinary albumin to 
creatinine ratio. Rats subjected to hypoxia showed ~9 fold increase in albumin excretion 
compared with control rats (Fig 1C). Furthermore, urinary fractions collected from rats 
exposed to hypoxia had a significant amount of protein as assessed by SDS-PAGE and 
visualized by silver staining (Fig 1D). We measured the extent of glomerulosclerosis in 
PAS-stained glomeruli and found that increased Bowman’s space, mild and diffuse 
glomerulosclerosis (Fig 1E&F) and reduced glomerular tuft area (Fig 1G) in rats 
exposed to hypoxia. Average glomerular tuft area in rats exposed to hypoxia was 1.8 
μm2 compared with 2.25 μm2 in control rats. All these data suggest altered glomerular 
architecture and increased glomerular permeability as evidenced by proteinuria in rats 
exposed to hypoxia. 
 
Chronic hypoxia-induced podocyte injury in vivo: 
 To understand the causative factors for proteinuria in rats exposed to hypoxia, 
we next investigated whether there are any differences in podocyte count and podocyte 
structure, using immunochemistry and TEM techniques, respectively. We stained 
glomerular sections for WT1, a putative marker for podocytes in order to study the effect 
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of hypoxia on quantification of podocytes (Fig 2A). We noticed ~39% decrease in 
podocytes number in experimental rats. When compare with podocyte count of 23±4 
per glomeruli in control rats, rats exposed to hypoxia had a count of 14±5 (Fig 2B).  To 
ascertain the podocyte morphology, we performed TEM analysis and observed foot-
processes effacement and disruption of slit-diaphragm from rats exposed to hypoxia 
(Fig 2C). TEM images also revealed that there are no noticeable changes in glomerular 
basement membrane and endothelium between control and experimental rats (Fig 2C). 
All these data suggest podocyte injury in rats exposed to hypoxia. 
 
Chronic hypoxia-induced glomerular ZEB2 expression: 
Since, we observed significant morphological and functional changes in the 
glomerular region, particularly in podocytes of rats exposed to hypoxia, we would like to 
understand the molecular basis for the observed pathological changes. HIF1α is a major 
transcription factor that regulates the adaptive response to hypoxia. Earlier studies 
suggest that activation of HIF1α is associated with progressive glomerulonephritis, 
epithelial to mesenchymal transition (EMT), fibrosis and renal failure (28). Considering 
the significance of HIF1α under hypoxic conditions, we investigated HIF1α expression in 
the glomerular region of rats exposed to chronic hypoxia. As expected, we observed 
elevated expression of HIF1α in the glomerular region of rats exposed to hypoxia (Fig 
3A&B). Further, induction of HIF1α is correlated with the up-regulation of its 
downstream targets including Tissue Transglutaminase (TG2), VEGFA, MMP2, and 
MMP9 and decreased expression of podocyte-specific proteins nephrin and podocin 
(Fig 3A&B). In addition to these canonical HIF1α targets, we have also analyzed the 
expression of ZEB2 in the glomerular region of the kidney, since ZEB2 gets upregulated 
during podocyte injury and elevated ZEB2 expression is associated with podocyte 
depletion (26,29). Interestingly, we observed an elevated ZEB2 expression in 
glomerular extracts from rats subjected to hypoxia, as measured at both protein (Fig 3A) 
and mRNA (Fig 3B) levels. Immunofluorescence data confirms an elevated expression 
of both HIF1α and ZEB2 in glomerular regions exposed to hypoxia (Fig 3C). The data 
suggest that elevated expression of glomerular HIF1α during hypoxia is associated with 
increased ZEB2 expression in proteinuric rats. 
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Expression of ZEB2 and ZEB2-NAT is associated with EMT of human podocytes: 
 ZEB2, which was increased in glomerular extracts of hypoxic rats, is chosen for 
further analysis owing to its established role in EMT of glomerular podocytes and 
altering podocyte permeability (26,30). ZEB2 is also involved in the development of the 
kidneys (31). ZEB2 genomic locus also expresses ZEB2-NAT in antisense manner and 
is known to bind complementary region on ZEB2 mRNA and mask the factors that 
would otherwise induce splicing (17,32). Thus, binding of ZEB2-NAT to ZEB2 mRNA 
prevents its splicing and augments ZEB2 mRNA translation (26). We found elevated 
expression of ZEB2-NAT in addition to ZEB2 mRNA in glomerular extracts of rats 
exposed to hypoxia (Fig 4A), indicating dual regulation of ZEB2 mRNA under hypoxic 
conditions; both at transcriptional (pre-mRNA) and translational (post-mRNA) levels. 
Upon confirming the elevated expression of ZEB2 in hypoxic rats, we assessed the 
expression of ZEB2 target genes and EMT markers: E-cadherin, a predominant 
epithelial marker; P-cadherin and ZO-1, constituents of cell-cell junctions; N-cadherin, 
vimentin, and β-catenin are mesenchymal markers. ZO-1, E- and P-cadherin were 
down-regulated, whereas N-cadherin, vimentin, and β-catenin were up-regulated in rat 
glomerular extracts in response to hypoxia (Fig 4A&B). To validate the observations 
found in rats also holds true in humans, we analyzed the expression of the same set of 
genes in Nakagawa Chronic Kidney Disease (CKD) dataset available at Nephroseq 
(https://nephroseq.org). This analysis revealed co-expression of HIF1α, ZEB2, β-catenin 
in Chronic Kidney Disease dataset (Fig 4C). It should be noted that elevated expression 
of HIF1α is also associated with loss of nephrin and podocin in CKD patients (Fig 4C). 
Thus, human renal genome-wide gene expression analysis also suggests a direct 
association of elevated HIF1α levels with loss of podocyte-specific gene expression.  
 
Hypoxia induces HIF1α and ZEB2 expression in podocytes in vitro: 
 Glomerular podocytes are instrumental to ensure glomerular permselectivity (7). 
It was reported that podocytes undergo EMT and such a glomerular injury with reduced 
podocyte count was associated with proteinuria (29,33). In order to investigate whether 
the observed proteinuria and decreased podocyte count in rats exposed to hypoxia 
were owing to podocyte injury, we then investigated the effect of hypoxia on human 
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immortalized podocytes. As anticipated, upon exposure to hypoxia, we noticed the 
accumulation of HIF1α in podocytes (Fig 5A&B). In addition, we also observed elevated 
expression of ZEB2 and N-cadherin along with decreased expression of E- and P- 
cadherins (Fig 5A&B). We observed induction of ZEB2-NAT in podocytes exposed to 
hypoxia (Fig 5B), similar to the observations made in rat glomerular extracts. Next, we 
investigated if there is any co-localization of HIF1α and ZEB2 in the podocytes upon 
exposure to hypoxia (Fig 5C). In podocytes cultured under normoxia, we observed very 
low levels of HIF1α. In cells exposed to hypoxia HIF1α levels were elevated and 
predominantly found in the nucleus (Fig 5C). ZEB2 was also increased in podocytes 
during hypoxic conditions (Fig 5C). Together, these data obtained from podocytes (Fig 
5C) and glomerular sections (Fig 3C) suggest that both HIF1α and ZEB2 are localized 
to glomerular podocytes during hypoxic conditions. Elevated expression of ZEB2 in 
podocytes was associated with cadherin switch as evidenced by attenuation of epithelial 
cadherins (E-and P-cadherins) and acquisition of mesenchymal cadherin (N-cadherin) 
(Fig 5A&B). In order to ascertain the elevated expression of ZEB2 during hypoxia 
ensures cadherin switch, we assessed cadherin expression in HEK293T cells that 
ectopically express ZEB2 (Fig 5D). Ectopic expression of ZEB2 resulted in the loss of E-
and P-cadherin and increase in N-cadherin (Fig 5D). Cadherin switch that is associated 
with EMT imparts enhanced migratory ability to cells (34). Therefore, we next assessed 
the migratory properties of cells naïve to hypoxia or exposed to hypoxia. Both, 
podocytes and HEK293T cells exposed to hypoxia showed enhanced migratory 
properties as assessed by wound healing assay (Fig 6A-C), a typical feature of cells 
that had undergone a phenotypic switch from epithelial to mesenchymal state. In order 
to verify, whether the enhanced migratory properties of these cells are indeed due to 
elevated ZEB2 expression, we assessed migratory properties of HEK293T cells that 
ectopically express ZEB2. Cells overexpressing ZEB2 (Fig 6D) showed enhanced 
migratory properties upon exposure to hypoxia (Fig 6E). Taken together these data 
suggest the existence of a strong positive correlation of HIF1α and ZEB2 expression in 
the podocytes during hypoxia and induction of ZEB2 ensures podocytes acquire 
mesenchymal phenotype. 
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HIF1α increases ZEB2 and ZEB2-NAT promoter activity: 
 To investigate the effect of HIF1α on ZEB2 promoter activity, we transiently 
transfected HEK293T cells with ZEB2 promoter-luciferase constructs and measured 
luciferase activity in the cell lysates with and without hypoxia treatment. We observed 
an increase in ZEB2 promoter activity in cells exposed to hypoxia (Fig 7A). Similarly, 
ZEB2-NAT promoter activity was also increased with hypoxia (Fig 7A). To verify the 
specificity of the effect of HIF1α on ZEB2 promoter activity, we tested the effect of 
hypoxia on the promoter of an unrelated gene, growth hormone receptor (GHR). 
Hypoxia had no effect on GHR promoter activity (Fig. 7A).  
 HIF1α binds to hypoxia response element (HRE) and activates the transcriptional 
activity of target genes. HRE possess two core sequences; 5’-CACGT-3’ and 5'-
GCGTG-3' (35,36). HREs are located at +104/+108, and +176/+180 region in 5’UTR of 
ZEB2 gene (Fig. 7B). To ascertain the occupancy of HIF1α on the ZEB2 genomic loci, 
we engineered ZEB2-promoter luciferase construct with a mutation in the HREs that 
abrogate HIF1α binding to ZEB2 promoter and tested the effect of hypoxia on the 
activity of this mutant luciferase reporter construct. Site-directed mutations in HREs of 
ZEB2 promoter failed to elicit ZEB2 promoter-reporter activity in cells exposed to 
hypoxia (Fig 7B). These results suggest that functional HREs present on the ZEB2 
promoter are essential for ZEB2 expression under hypoxic conditions.  
 In order to assess the elevated expression of ZEB2 during hypoxia is due to 
HIF1α occupancy on the ZEB2 promoter, we next performed chromatin 
immunoprecipitation (ChIP) assay. ChIP assay confirmed that HIF1α occupies ZEB2 
promoter in vivo at the HRE’s in response to Hypoxia (Fig 7C). The specificity of these 
associations was verified by demonstrating a lack of binding to a region adjacent to 
HRE’s in the ZEB2 promoter. We utilized the interaction of HIF1α with the promoter 
region of VEGFA, which serves as a positive control (37) for the experimental conditions 
as VEGFA promoter has HRE (Fig 7C). As we observed that ZEB2-NAT was also 
expressed under hypoxic condition, we performed promoter analysis of ZEB2-NAT for 
the presence of HREs. We observed HRE sequence (‘GCGTG’) at two regions of 
ZEB2-NAT promoter +1145/+1149 and +2945/+2949. Together, this data suggests that 
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HIF1α elicits ZEB2 protein accumulation by inducing both ZEB2 mRNA and ZEB2-NAT 
expression wherein ZEB2-NAT augments the expression of ZEB2 mRNA. 
 
ZEB2 knockdown prevents HIF1α-dependent decrease in E-cadherin in 
podocytes: 
 We next investigated whether ZEB2 plays an essential role in the HIF1α-
mediated podocyte injury. For this, we utilized podocytes in which ZEB2 expression was 
knocked down using shRNA-mediated approach. After having confirmed the efficacy 
and specificity of knockdown (Fig 7D), these cells were exposed to hypoxia, and the 
expression of E-cadherin was measured by immunoblotting. In podocytes transfected 
with lentivirus expressing ZEB2 shRNA, exposure to hypoxia failed to elicit the decrease 
in E-cadherin expression (Fig 7E). These results suggest that ZEB2 is essential for 
transducing the effect of HIF1α on E-cadherin expression in the podocytes. Further, we 
investigated the temporal association of HIF1α-induced ZEB2 on E-cadherin expression 
using E-cadherin promoter construct. E-cadherin promoter has two E2-boxes (E2-box1: 
‘CAGGTG’ & E2-box3: ‘CACCTG’) wherein ZEB2 interacts and transduces the 
repressive action on E-cadherin expression. The specific effect of HIF1α-induced ZEB2 
on E-cadherin expression was analyzed using E-cadherin (E-cad) construct in which 
ZEB2 binding sites (E2 boxes) were mutated (E-cad-E2M). While hypoxia treatment 
decreased the activity of E-cad WT promoter activity, it had no effect on E-cad-E2M (Fig 
7F), suggesting that the observed loss of E-cadherin expression in hypoxia conditions is 
due to ZEB2 overexpression. 
 
Essential role of ZEB2 in eliciting the effect of HIF1α on the permeability of 
podocytes: 
To assess the functional consequence of hypoxia on podocyte function, we next 
examined the podocyte permeability employing paracellular albumin influx assay. This 
assay measures the rate of albumin flux across the podocyte monolayer plated on 
semipermeable PTFE membrane inserts (Fig 8A). After 24h of exposure to hypoxia, 
albumin was placed in the bottom chamber of transwell and the influx of albumin across 
the podocyte monolayer was measured at 1h and 4h intervals. Increased albumin influx 
was noticed across the podocyte monolayer that was exposed to hypoxia (Fig 8B). 
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These results revealed a hypoxia-dependent increase in albumin influx across the 
podocyte monolayer. To delineate the role of HIF1α on the permeability of the podocyte 
monolayer, we next investigated the effect of HIF1α in podocytes in which ZEB2 
expression was knocked down. Knocking down of ZEB2 expression resulted in blunting 
the ability of hypoxia to elicit an increase in the albumin influx across podocyte 
monolayer (Fig 8B). These results suggest that ZEB2 is necessary for transducing the 
effect of hypoxia on podocyte permeability. All these data confirm that ZEB2 is the key 
player in eliciting the proteinuric effect of elevated HIF1α expression in the podocytes 
during hypoxic conditions, wherein hypoxia induces HIF1α expression, which 
recognizes and binds to HREs on the ZEB2 promoter and transactivates its expression. 
ZEB2, in turn, regulates the expression of EMT genes, and repression of slit-diaphragm 
components resulting in increased permeability. 
 
DISCUSSION 
Prevalence of glomerular dysfunction is prominent in clinical conditions and 
adverse environmental conditions where hypoxia prevails. Nevertheless, the 
pathological events that connect hypoxia to glomerular dysfunction remain largely 
unknown. We took up the current investigation to understand the pathophysiological 
basis of the effects of chronic hypoxia on glomerular podocytes. Our study revealed that 
in rats exposed to chronic hypoxia, HIF1α is elevated in glomerular regions. Our results 
indicate a novel target of HIF1α is the induction of ZEB2. This increase in ZEB2 
expression is due to the up-regulation of ZEB2 mRNA and the induction of NAT of the 
ZEB2 gene. We demonstrated that HIF1α-dependent induction of ZEB2 in the 
podocytes results in decreased expression of P- and E-cadherin. P-cadherin is a 
component of the podocyte slit-diaphragm (38), and E-cadherin anchors epithelial 
junctions and participates in EMT (39). Our studies also establish that accumulation of 
HIF1α increases permeability of a podocyte monolayer, and this effect is a 
consequence of HIF1α-dependent induction of ZEB2. A hyperactive HIF1α-ZEB2 axis is 
implicated in the altered podocyte biology, both by initiating EMT and altered 
permeability to the slit-diaphragm (Fig 8C); and our results provide a molecular basis for 
the role of hypoxia in the pathogenesis of glomerular diseases.  
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The hypoxic condition results in decreased arterial oxygen pressure that could 
affect multiple organs including the kidney. Arterial oxygen pressure is maintained at 
relatively stable levels by a unique and complex functional interplay between renal 
blood flow, GFR, oxygen consumption, and arteriovenous oxygen shunting (40,41). The 
fragility of this interplay makes the kidney vulnerable to hypoxic injury (40). Renal cells 
have evolved a variety of molecular mechanisms to adapt to hypoxic conditions that 
prevail during development, under extreme physiological and pathological conditions. 
HIF1α is a predominant transcription factor involved in the control of hypoxia and 
oxidative stress responses. It is noteworthy that intra-renal hypoxia is a proposed 
pathway to renal dysfunction in conditions such as diabetes and hypertension (42). 
Proteinuria is a predominant manifestation of glomerular dysfunction and it refers to the 
alterations particularly in GFB that otherwise offers permselectivity and prevents loss of 
protein in the urine. Therefore, we investigated the effect of hypoxia in renal cortex, the 
region where glomeruli are concentrated, and in podocytes that are instrumental to 
ensure permselectivity. It is interesting to note that HIF1α levels have been reported to 
be elevated in many organs including liver, brain, and kidney in response to hypoxia 
and influence target gene expression (43). Similarly, in our model HIF1α levels were 
significantly upregulated in the kidney compared to liver, and brain.  
Our results establish that hypoxia-induced accumulation of HIF1α stimulates the 
expression of ZEB2. ZEB2, also known as Smad-interacting protein-1 (SIP1) and 
ZFHX1B, belongs to the ZEB protein family. ZEB2 acts as a transcriptional repressor in 
both C-terminal binding protein (CTBP) dependent and independent manner (44). The 
expression of ZEB2, a critical transcriptional factor that orchestrates EMT phenomenon 
is regulated by cis-NAT. We observed expression of ZEB2-NAT in podocytes exposed 
to hypoxia. Since ZEB2 has many potential targets including crucial proteins of tight 
junctions, adherence junctions and gap junctions (45), the increase in ZEB2 could have 
pleiotropic effects on the podocyte biology during hypoxia. E-cadherin is a canonical 
target for transcriptional repression by ZEB2. E-cadherin exists in cytoplasmic vesicles 
in podocytes in culture (38). The role of E-cadherin in EMT phenomenon is well 
established, wherein E-cadherin expression is down-regulated during the transition of 
cells from epithelial to mesenchymal phenotype (46). P-cadherin, another bonafide 
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target of ZEB2, belongs to the cadherin superfamily and is a component of the slit 
diaphragm apparatus. Decreased expression of P-cadherin is implicated in the 
pathogenesis of proteinuria and glomerulosclerosis (47,48). P-cadherin mediates cell-
cell adhesion between adjacent podocyte foot processes and also serves as the basic 
scaffold for the slit-diaphragm. It is noteworthy that the key findings of the current study, 
HIF1α-dependent increase in ZEB2 and the resultant decrease in E- and P-cadherins, 
were observed in both HEK cells and human podocytes. In podocytes with a ZEB2 
knockdown, HIF1α accumulation fails to provoke the loss of E-cadherin; whereas 
ectopically expressed ZEB2 elicited further loss of E-cadherin expression. Furthermore, 
elevated ZEB2 expression altered the permselectivity of podocytes to albumin. These 
results indicate that ZEB2 is essential for transducing the HIF1α effects on the 
permeability of the podocyte monolayer. In addition to ZEB2, there are other 
transcription factors that elicit EMT phenomenon including ZEB1, Snail, and Slug. We 
observed that basal level ZEB2 expression in podocytes was relatively much higher 
than compared with other transcription factors that induce EMT, while ZEB1 protein 
expression was only minimally increased during hypoxia (data not shown).  
Besides the loss of E- and P-cadherin expression, several other proteins are also 
deregulated during EMT of podocytes including nephrin and podocin (33). We found 
attenuated expression of ZO-1 and increased expression of N-cadherin, β-catenin, and 
vimentin in rats exposed to hypoxia. ZO-1 is a component of tight junctions, which plays 
a vital role in regulating permeability across the epithelium. The decreased expression 
of ZO-1 in podocytes exposed to hypoxia could disrupt the permeability barrier of the 
podocytes. The loss of ZO-1 expression in our study is concurrent with earlier studies 
that reported the loss of tight junction proteins under ischemic conditions (49). We have 
also observed the loss of podocyte-specific proteins nephrin and podocin in cells 
exposed to hypoxia. These two proteins are crucial components of podocyte slit-
diaphragm and loss of their expression, particularly nephrin, a major determinant of 
glomerular vascular permeability correlates with a loss of glomerular filter integrity (50). 
Expression of nephrin and podocin is also decreased during EMT of podocytes (51). 
  The results from this study show that ZEB2 expression is induced in 
podocytes under hypoxic conditions. We demonstrate that ZEB2 promoter has HREs 
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and HIF1α interacts with these HRE1 and HRE2 (5’-GCGTG -3’ & 5’-CACGT-3’). 
Activation of ZEB2 gene transcription is evidenced by an increase in ZEB2 promoter 
activity under hypoxic conditions. It is known that expression of the ZEB2 is controlled at 
multiple levels, including transcriptional and post-transcriptional. Post-transcriptional 
regulation of ZEB2 is mediated by ZEB2-NAT, wherein ZEB2-NAT binds to a 
complementary region on ZEB2 mRNA. Binding of ZEB2-NAT with ZEB2 mRNA 
preserves Internal Ribosome Entry Site (IRES) of ZEB2 mRNA by preventing splicing of 
an intron in ZEB2 mRNA. ZEB2-NAT mediated control of ZEB2 expression has been 
described in earlier studies (17,35). Interestingly, in addition to the ZEB2 expression, we 
identified the induction of ZEB2-NAT in hypoxic conditions. Our study reveals that a 
two-level regulation of ZEB2 expression by HIF1α under hypoxic conditions. In addition 
to our own observations, meta-data analysis from Nephroseq also revealed that 
elevated expression of HIF1α is associated with ZEB2 overexpression in chronic kidney 
diseases. Hence, increased HIF1α and ZEB2 expression is not only confined to loss of 
glomerular function under hypoxic conditions but is also relevant to the pathogenesis of 
glomerular dysfunction in chronic kidney disease. 
This report establishes a mechanism for the effect of chronic hypoxia on 
glomerular dysfunction. A novel observation of this study is that hypoxia induces HIF1α, 
which in turn increases ZEB2 expression in the podocytes, and this action of HIF1α is 
mediated, in part, via increased expression of ZEB2-NAT. The HIF1α-dependent 
increase in ZEB2 ensures both EMT of podocytes and podocyte foot-processes 
effacement. ZEB2 is critical for HIF1α to exert its deleterious effect on glomerular 
function in hypoxia via changes in the epithelial phenotype and permselectivity of 
podocytes. We propose that the HIF1-dependent increase in ZEB2 plays a key role in 
transducing the podocyte injury under hypoxic conditions and that the HIF-ZEB2 axis 
could be a molecular basis for podocyte loss and proteinuria during hypoxic conditions 
that prevail during several pathological and extreme physiological conditions.  
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Figure Legends: 
Figure 1: Chronic hypoxia alters renal function. (A) Outline of animal experiment. 
Control rats were maintained at normoxia (24hX2 weeks) and experimental rats were 
exposed to hypoxia (23hX2 weeks). After 2 weeks, we assessed renal function tests 
and histological parameters. (B) Measurement of glomerular filtration rate (GFR) in rats 
exposed to hypoxia. n=6; *, p≤0.01. (C) Estimation of Albumin and creatinine levels in 
rats exposed to hypoxia. The ratio of Albumin/Creatinine is shown in the form of bar 
diagram in each condition. n=6, *, p≤0.01 (D) Urine protein analysis in rats exposed to 
hypoxia. Urine samples were subjected to SDS-PAGE and band intensities were 
visualized by silver staining as described in “materials and methods”. M- molecular 
weight marker (Bio-Rad#1610374), C- urine from control rat, H-urine from the rat 
exposed to hypoxia, and BSA was used as a standard. (E) PAS staining of glomerular 
regions of rats exposed to hypoxia. (F) Glomerulosclerosis index was assessed as 
described in the methods section and  (G) Measurement of glomerular tuft area in rats 
exposed to hypoxia. Error bars indicate mean ± SE; n=6. *, p≤0.05. 
 
Figure 2: Hypoxia induces podocyte injury. (A) WT1 staining of glomerulus from rats 
exposed to hypoxia. (B) Quantification of podocyte number in these rats. Error bars 
indicate mean ± SE; n=6. *, p≤0.05. (C) TEM images of podocytes from rats exposed to 
hypoxia. These are a representative image out of 12 sections from each condition. 
Podocyte foot-processes effacement and disruption of slit-diaphragm can be noticed 
from rats exposed to hypoxia. Significant alterations in the morphology of podocytes 
occurred in rats exposed to hypoxia are indicated with (*) mark.  
 
Figure 3: Elevated expression of HIF1α in rat glomerular extracts. Expression of 
HIF1α and its targets in rat glomerular extracts is shown as analyzed by immunoblotting 
(A) and qRT-PCR (B). Densitometric analysis of western blots (n=3-4) was normalized 
to β-actin expression and is shown below each blot (A). Error bars (B) indicate mean ± 
SE; n=4. *, p≤0.05. (C) Immunofluorescence analysis of HIF1α and ZEB2 in the rat 
glomeruli. Images were captured at 60X using a Leica trinocular microscope.  
 
Figure 4: Elevated expression of EMT markers in rat glomerular extracts. qRT-
PCR (A) and immunoblotting (B) showing the expression of ZEB2, ZEB2-NAT and EMT 
markers. Error bars (A) indicate mean ± SE; n=4. *, p≤0.05. (B) Densitometric analysis 
of ZEB2 targets normalized for β-actin expression is shown below each blot (n=3-4). (C) 
Nephroseq (The Regents of The University of Michigan, Ann Arbor) analysis comparing 
HIF1α, β-catenin, ZEB2, nephrin and podocin expression levels from patients with 
chronic kidney disease (CKD) vs. control. Expression of HIF1α (2.62 fold), β-catenin 
(1.70 fold) and ZEB2 (2.7 fold) are increased; nephrin and podocin expression is 
decreased several-fold among patients with CKD. 
 
Figure 5: Hypoxia induces HIF1α, ZEB2 and EMT markers in human podocytes. 
Immunoblotting (A) and qRT-PCR (B) analysis of HIF1α, ZEB2, and its targets in human 
podocytes exposed to hypoxia. (A) Densitometric analysis of protein expression was 
normalized for β-actin expression and is shown below each blot (n=3-4).  (B) The data 
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presented as mean ± SE; n=4-6. *, p< 0.05.  (C) Immunofluorescence images showing 
elevated expression and co-localization of HIF1α and ZEB2 in podocytes exposed to 
hypoxia. Images were acquired using ZEISS confocal microscope. (D) qRT-PCR 
analysis of cadherins in HEK293T cells that ectopically express ZEB2, mean ± SE; n=4-
6. *, p≤0.05.    
 
Figure 6: Elevated expression of ZEB2 induces enhanced migration of podocytes. 
Wound healing assay showing the enhanced migration of human podocytes (A) and 
HEK293T cells (B) exposed to hypoxia for varying periods of time. (C) Cell migration is 
monitored and presented as % area covered. (D) Western blot analysis of ZEB2 in 
HEK293T cells overexpressing ZEB2 and quantification of band intensities. (E) Wound 
healing assay of HEK293T cells  (control and ZEB2 overexpressing) and cell migration 
is monitored and presented as % area covered. The data (C-E) presented as mean ± 
SE; n=4-6. *, p≤0.05.    
 
 
Figure 7: Hypoxia induces HIF1α-ZEB2 axis. (A) Luciferase assay in HEK293T cells 
transiently transfected with indicated constructs and exposed to hypoxia for 24 h. 
Renilla luciferase was used as an internal control to normalize transfection efficiency. 
(B) Left panel - Schematic representation of ZEB2 5’UTR showing localization of 
hypoxia response elements (HREs) and point mutations in HREs. Right panel -  
HEK293T cells were transiently transfected with ZEB2 promoter-luciferase (ZEB2-WT) 
or ZEB2 promoter-luciferase construct with point mutations in the both HREs (ZEB2-
H2M) and exposed to hypoxia for 24 h. Renilla luciferase is used to normalize 
transfection efficiency. The normalized luciferase activity for each individual construct 
exposed to normoxia is designated as 1 fold. (C) ChIP analysis with chromatin fractions 
from HEK293T cells exposed to hypoxia was performed as described. Input DNA and 
DNA from each of the immunoprecipitated samples were PCR amplified for HRE in both 
ZEB2 promoter and VEGFA promoter. (D) Western blot analysis of ZEB2 showing the 
efficiency of ZEB2 shRNA. (E) Western blot analysis showing E-cadherin expression in 
human podocytes transduced with a lentiviral construct expressing ZEB2 shRNA with 
and without hypoxia. (F) Left panel - Schematic representation of E-cadherin promoter 
region showing localization of E2-box1 and E2-box3 and point mutations in both E2-
boxes. Right panel - HEK293T cells were transiently transfected with E-cadherin 
promoter-luciferase (E-cad-WT) or E-cadherin promoter-luciferase construct with point 
mutations in the both E2-box1 and 3 (E-cad-E2M) and exposed to hypoxia for 24 h. 
Renilla luciferase is used to normalize transfection efficiency. The normalized luciferase 
activity for each individual construct exposed to normoxia is designated as 1 fold. The 
data (A, B, C and F) presented as mean ± SE; n=4-6. *, p≤0.05.    
 
 
Figure 8: Activation of HIF1α-ZEB2 axis alters podocyte permselectivity. (A) A 
simplified schematic representation of the paracellular permeability assay adopted to 
assess the filtration barrier function of podocyte monolayer. Podocyte monolayer on 
collagen-coated transwell filters was allowed to differentiate as described in method 
section and exposed to hypoxia for 24 h. Albumin was placed in the bottom chamber 
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and its migration to the upper chamber was determined at respective intervals. (B) 
Quantification of albumin influx across podocyte monolayer. Albumin influx is 
determined at 1 and 4 h following the 24 h exposure to hypoxia. Podocytes transduced 
with a lentiviral construct expressing scrambled RNA were considered as a control. The 
data presented as mean ± SE; n=4-6. *, p< 0.05. (C) Proposed model for hypoxia-
mediated podocyte injury. Upon exposure to hypoxia, HIF1α accumulates, which in turn 
occupies ZEB2 promoter and drives its expression. ZEB2, in turn, suppresses both P- 
and E-cadherins to induce EMT. Decreased E-cadherin expression is implicated in EMT 
that results in podocyte dehiscence and loss. These changes in P- and E-cadherin 
expression will manifest in effacement of podocyte foot-processes and proteinuria in 
pathological states of overactivity of HIF1α -ZEB2 axis in the kidney (CL- capillary 
lumen; US- urinary space; G-glomerular basement membrane; E-endothelium). 
